The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

Gabi W. van Pelt, Marije Slingerland(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Arantza Fariña Sarasqueta(Leiden University), Irene M. Lips(Leiden University Medical Center), Wobbe O. de Steur(Leiden University Medical Center), Wilma E. Mesker(Leiden University Medical Center), Janna Krol(Leiden University Medical Center), David van Klaveren(Erasmus MC), Jurjen J. Boonstra(Leiden University Medical Center), Femke P. Peters(The Netherlands Cancer Institute)
Clinical and Translational Radiation Oncology
November 26, 2019
10.1016/j.ctro.2019.11.003
Cited by 42

Related Papers

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
|The Lancet|2013|827
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains
|Nature Genetics|2011|695
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer
|British journal of surgery|2004|665
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
|Genome Research|2011|610